Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
2002, Advances in Behavioral Biology
…
3 pages
1 file
In this manuscript, we assess whether the prevalence of Parkinson disease (PD) among famous people is greater than in a sample of all people. We compared the prevalence of PD in two populations: The first population included people who were named TIME magazine's Person of the Year, a contemporary measure of fame. The second population considered for analysis included people enrolled in the EuroParkinson Collaborative Study.
Parkinsonism & Related Disorders, 2000
We describe Parkinsonism in prominent people, where Wilhelm von Humboldt and Adolf Hitler provide just two spectacular, opposing examples. In both of them, there is little if any evidence that the disease did in¯uence their life ambitions, methods of achieving them or cognitive function in general. Thus, Hitler's Parkinsonism should remain a`footnote' to history, and historians should acknowledge that in his last years, his trembling, his curbed posture, his slow walking, mask-like face and low voice did not indicate remorse, fear or depression as a consequence of his crimes, but were mere expressions of his disease which, until the end, had no impact on his intellectual skills and methods. The apparently higher incidence of Parkinsonism in prominent people may be just due to their higher visibility, or a consequence of disease-related personality traits (e.g. ambition, perfectionism, rigidity) which may contribute to becoming, e.g., a prominent authoritarian person. Perhaps even some early behaviour pattern (such as repressed emotions or acting in public±which could even increase the risk of some infection) contributes to a greater vulnerability for developing Parkinsonism. Further studying other prominent cases might lead us to better understanding of risk factors and the expression of early Parkinsonism. q
JAMA Neurology, 2016
To the Editor We read with interest the article by Savica et al, 1 who described an increase in the incidence rate of parkinsonism in the Rochester Epidemiology Project between 1976 and 2005. This finding contradicts our recently reported observation that the incidence rate of parkinsonism was lower in a subcohort of the Rotterdam Study that was followed up between 2000 and 2011 compared with a subcohort that was followed up between 1990 and 2000. 2 Similarly, a UK primary care study previously reported a significant decline in Parkinson disease (PD) incidence rates between 1999 and 2009. 3 Savica et al 1 hypothesized that the changes observed in the Rochester Epidemiology Project could be attributed to a decrease in the prevalence of smoking in the second half of the 20th century, but they were unable to test this hypothesis in their cohort. Within the Rotterdam Study, we assessed smoking habits at baseline of both subcohorts (1990 and 2000). As expected, we observed that the ageand sex-adjusted prevalence of current smoking was lower across all ages (55-106 years) in the subcohort that started in 2000. 2 During follow-up, incident parkinsonism was diagnosed in 182 of 6752 persons in the subcohort that started in 1990, and in 28 of 2440 persons in the subcohort that started in 2000. The age-and sex-adjusted incidence rate (IR) of parkinsonism for smokers was similar in both subcohorts (IR, 0.63; 95% CI,0.43-0.91 in the 1990 subcohort; IR, 0.61; 95% CI, 0.27-1.44 in the 2000 subcohort). The age-and sex-adjusted incidence rate ratio (IRR) for parkinsonism of persons in the 2000 subcohort vs the 1990 subcohort was 0.55 (95% CI, 0.36-0.81). After additional adjustment for smoking status, the IRR remained virtually unchanged (IRR, 0.57; 95% CI, 0.37-0.84). Unfortunately, the small number of PD cases in the 2000 subcohort prevented PD-specific analyses on the effect of smoking. We conclude that it is unlikely that the decline in smoking prevalence drove a change in the incidence of parkinsonism in the Rotterdam Study. The discrepant findings of the study by Savica et al 1 compared with previous studies, including the Rotterdam Study, highlight the lack of insight on causality of risk factors for parkinsonism and PD. For smoking in particular, causality of its inverse association with the risk for parkinsonism and PD remains highly contentious, 4 and the inference that the increase in parkinsonism incidence in the Rochester Epidemiology Project can be attributed to a decline in smoking may shift focus from other putative etiological factors. To better understand factors that drive differential trends in the incidence of parkinsonism across populations, there is an urgent need for cross-cohort collaboration, similar to recently initiated efforts for dementia. 5
Movement disorders : official journal of the Movement Disorder Society, 2017
Previous studies have estimated future PD prevalence based on population aging. This study revisits that projection by accounting for the potential impact of declining rates of smoking. The age- and gender-stratified smoking prevalence in the United States from 2000 to 2040 were obtained from the U.S. Census Bureau and the U.S. Surgeon General's Smoking Report. PD prevalence was estimated based on population aging with and without an account of the impact of declining smoking rates. Relative risks of 0.56 and 0.78 were applied for current and former smokers, respectively. Accounting for aging alone, ∼700,000 PD cases are predicted by 2040. After accounting for the declining smoking prevalence, ∼770,000 cases, an increase of ∼10% over the estimate without smoking, is predicted. If the epidemiological association of smoking and PD is causal, projecting future cases without considering smoking may underestimate disease burden, underscoring the urgency of adequate resource allocatio...
Journal of Parkinson's disease, 2018
Recent epidemiological observations have drawn attention to the rapid rise in the burden caused by Parkinson's disease over the past years, emphasizing that Parkinson's disease is a matter of serious concern for our future generations. A recent report by Public Health England corroborates this message, by providing new insight on trends in deaths associated with neurological diseases in England between 2001 to 2014. The report indicates that mortality associated with Parkinson's disease and related disorders increased substantially between 2001 and 2014. This trend is partially explained by increased longevity in the population. However, it is possible that changes in exposure to risk factors, recent improvements in multidisciplinary care (leading to prolonged survival), and improved diagnostic awareness or improved registration also influenced the observed trend. Furthermore, patients with Parkinson's disease and related disorders were found to die at an advanced ag...
Journal of …, 2004
Southern Medical Journal, 2012
More than 1 million people in the United States have Parkinson disease (PD), more than are diagnosed as having multiple sclerosis, amyotrophic lateral sclerosis, muscular dystrophy, and myasthenia gravis combined. PD affects approximately 1 in 100 Americans older than 60 years. It burdens patients, their care partners, and the overall healthcare system. This article reviews the epidemiology, clinical features, putative environmental risk and protective factors, neuropathological aspects, heterogeneity, medical management, and recent studies regarding genetics and PD. The article suggests that based on new research, the prevalence of PD varies in different regions of the United States. Some progress has been made in identifying the risk and protective factors of PD, and a newly emphasized area of study in PD is genetics. Patient care recommendations, based on American Academy of Neurology practice guidelines, are outlined to show the state of contemporary medical management of PD and related disorders.
American journal of epidemiology, 2016
We investigated trends in the incidence of parkinsonism and Parkinson disease (PD) by comparing data from the first 2 subcohorts of the Rotterdam Study, a prospective, population-based cohort study (first subcohort: baseline 1990 with 10 years of follow-up; second subcohort, baseline 2000 with 10 years of follow-up). From the baseline years, we observed differences in the second subcohort that were associated with a lower risk of PD for some but not all baseline risk factors. Participants in both subcohorts were followed for a maximum of 10 years and monitored for the onset of parkinsonism, the onset of dementia, or death, until January 1, 2011. We used Poisson regression models to compare the incidences of parkinsonism, both overall and by cause (PD and secondary causes), and competitive events (incident dementia and death) as well as the mortality of parkinsonism patients in the 2 subcohorts. In the 1990 subcohort, there were 182 cases of parkinsonism (84 of which were PD) during ...
Parkinson's Disease, 2016
The multifactorial pathogenesis of Parkinson’s Disease (PD) requires a careful identification of populations “at risk” of developing the disease. In this case-control study we analyzed a large Italian population, in an attempt to outline general criteria to define a population “at risk” of PD. We enrolled 300 PD patients and 300 controls, gender and age matched, from the same urban geographical area. All subjects were interviewed on demographics, family history of PD, occupational and environmental toxicants exposure, smoking status, and alcohol consumption. A sample of 65 patients and 65 controls also underwent serum dosing of iron, copper, mercury, and manganese by means of Inductively Coupled-Plasma-Mass-Spectrometry (ICP-MS). Positive family history, toxicants exposure, non-current-smoker, and alcohol nonconsumer status occurred as significant risk factors in our population. The number of concurring risk factors overlapping in the same subject impressively increased the overall ...
Abstract: Primary parameters in defining the health condition of the human body are heartbeat, blood pressure and body temperature. Monitoring them all at once is a costly process. In this paper, a low cost and portable method is proposed and implemented to measure heartbeat, blood pressure and temperature from human body using the microcontroller device with LCD output. Heart rate of the subject is measured from the finger using infrared sensors. Blood pressure using wrist band and temperature by temperature sensor. The noisy output signal from the sensors is stripped out of unwanted components with the help of a hardware and then given to micro controller which is displayed on a text based LCD. Furthermore the same information is analyzed by microcontroller and an alert is triggered if those values fall out of the range of predefined threshold limits. This is useful to monitor vital parameters at low cost and trigger an alert to intimate this condition to care takers via message using a GSM modem Keywords: alerting, Heartrate; Bloodpressure monitering; temperature, cardiology, remote monitering;
Appunti per un'analisi degli effetti economici della guerra ucraina, in La guerra ucraina. Cause impatto conseguenze, a cura di A. Catone, [numero monografico di] MarxVentuno, n.1-2/2022, pp. 311-325 [rielaborazione di una relazione svolta il 19 aprile 2022] Indice: 1. Le conseguenze economiche 1.1. Effetti asimmetrici e divergenza delle economie 2. Le conseguenze monetarie e finanziarie 3. Le conseguenze sull'ordine monetario internazionale 4. Verso una bipartizione economica e finanziaria del mondo?
Revista Brasileira de Estudos Urbanos e Regionais, 2014
Immanuel 3 - 51-56, 1973
Variables de Instrumentación
Peabody Journal of Education, 2024
Journal of Civil Engineering and Architecture, 2018
Зорислава М. Васиљевић - живот и дело/Zorislava M. Vasiljevic - life and work, 2020
HIV Medicine, 2016
Journal of Biological Chemistry, 2011
Journal of Medicinal Food, 2011
akademikbakis.org
Revista de Gestão de Água da América Latina, 2013
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2021
Frontiers in Oncology
Indonesian Journal of Electrical Engineering and Computer Science, 2022